"ID","biorxiv","published","title","year","journal","doi","author","author_name","author_email","author_address","hypothesis","rationale","MR_design","outcome","outcome_info","outcome_group","outcome_definition","outcome_study","outcome_age_range","outcome_sex","outcome_n_case_current","outcome_n_control_current","outcome_n_case_og","outcome_n_control_og","outcome_n_difference_reason","outcome_health_status","outcome_population","exposure","exposure_definition","exposure_study","exposure_age","exposure_sex","exposure_n_current","exposure_n_og","exposure_n_difference_reason","exposure_health_status","exposure_population","exposure_covariates_model","exposure_genotyping_dataset","exposure_independence","exposure_pleiotropy","exposure_pvalue","exposure_palindrome","exposure_proxy","exposure_HWE","IV_single","IV_multiple","IV_GRS","n_SNP_og","n_SNP_difference_reason","power_calculation","power_calculation_how","MR_method","MR_sensitivity_method1","MR_sensitivity_method2","MR_sensitivity_method3","MR_sensitivity_method4","MR_sensitivity_method5","MR_sensitivity_method_results","IV_strength","analysis_software","analysis_programme","replication_independent","replication_subsetting","multiple_testing","exposure_units","outcome_units","effect_estimate","estimate","se","ci_percent","ci_lower","ci_upper","p","adjustment_method","p_adjusted","limitations_overall","limitations_pleiotropy","limitations_population_stratification","limitations_statistical_power","notes","ID_analysis"
2,"no","yes","Vitamin D concentration, obesity, and risk of diabetes:
a mendelian randomisation study",2014,"The Lancet Diabetes and Endocrinology","10.1016/S2213-8587(13)70200-6","Afzal","Prof Børge G Nordestgaard","boerge.nordestgaard@regionh.dk","Department of Clinical Biochemistry, Herlev Hospital, Copenhagen University Hospital, Herlev Ringvej 75, DK-2730 Herlev, Denmark","Effect of body mass index on diabetes","that genetically increased BMI is associated with low
plasma 25(OH)D concentration and with increased risk
of diabetes.","One-sample","type 2 diabetes","type 2 diabetes","metabolic","Not discussed","Current study","20-100","both","89457",NA,NA,NA,NA,"Healthy","European ancestry","BMI","BMI","Current study","20-100","both","89457",NA,NA,"Healthy","European ancestry","Adjusted for study","Not discussed",NA,NA,NA,NA,NA,"X2",NA,"3",NA,NA,NA,"No",NA,"Wald ratio",NA,NA,NA,NA,NA,"No sensitivty analysis performed","Yes","STATA","Not discussed","Not discussed","Not discussed","Not discussed","10 kg/m2","OR","OR","19.399999999999999",NA,"95","6.4","59.1","8.9999999999999993E-3",NA,NA,"Not discussed","Not discussed","Not discussed","Not discussed",NA,4
19,"no","yes","Mendelian randomization analysis of a time-varying exposure for binary disease outcomes using functional data analysis methods",2016,"Genetic Epidemiology","10.1002/gepi.22013","Cao","Peng Wei","pwei2@mdanderson.org","Department of Biostatistics, The University of Texas MD Anderson Cancer Center, 1400 Pressler St, Pickens Tower, FCT4.6044, Houston, TX 77030, USA","Effect of body mass index on type 2 diabetes and coronary artery disease","Method validation","One-sample","type 2 diabetes","type 2 diabetes","metabolic","Not discussed","Current study","25-75","both","171","1551",NA,NA,NA,"case/control","European","BMI","BMI","Guo 2013 BMI All ancestries both","18+","both","1722","108912","One-sample where they got exposure SNPs from external GWAS","Healthy","All ancestries","age, sex","Not discussed","Not discussed","Not discussed","Not discussed","Not discussed","Not discussed","Not discussed",NA,NA,"14","11","They say they used 14 SNPs from the GWAS by Guo et al but that GWAS only identified 11 so no idea where they got 3 extra SNPs from because there is no info","No",NA,"Baseline 2SRI","Not discussed",NA,NA,NA,NA,"Not discussed","13.25","Not discussed","Not discussed","Not discussed","Not discussed","Not discussed","kg/m2","case/control",NA,"effect of the GRS on BMI increases slowly from age 25 to 50 years, followed by a slow decrease",NA,NA,NA,NA,"1.4E-2",NA,NA,"the two new proposed methods are only aimed for hypothesis testing, not for causal effect size estimation. Time varying information not captured by single measurement. SNP weights may not be transferable from large to small population.","No validated methods at time of writing","Not discussed","Not discussed",NA,128
19,"no","yes","Mendelian randomization analysis of a time-varying exposure for binary disease outcomes using functional data analysis methods",2016,"Genetic Epidemiology","10.1002/gepi.22013","Cao","Peng Wei","pwei2@mdanderson.org","Department of Biostatistics, The University of Texas MD Anderson Cancer Center, 1400 Pressler St, Pickens Tower, FCT4.6044, Houston, TX 77030, USA","Effect of body mass index on type 2 diabetes and coronary artery disease","Method validation","One-sample","type 2 diabetes","type 2 diabetes","metabolic","Not discussed","Current study","25-75","both","171","1551",NA,NA,NA,"case/control","European","BMI","BMI","Guo 2013 BMI All ancestries both","18+","both","1722","108912","One-sample where they got exposure SNPs from external GWAS","Healthy","All ancestries","age, sex","Not discussed","Not discussed","Not discussed","Not discussed","Not discussed","Not discussed","Not discussed",NA,"14",NA,"11","They say they used 14 SNPs from the GWAS by Guo et al but that GWAS only identified 11 so no idea where they got 3 extra SNPs from because there is no info","No",NA,"Baseline 2SRI","Not discussed",NA,NA,NA,NA,"Not discussed","13.25","Not discussed","Not discussed","Not discussed","Not discussed","Not discussed","kg/m2","case/control",NA,"subjects with more effect alleles have higher fitted BMI values across their lifetime",NA,NA,NA,NA,"6.0999999999999999E-2",NA,NA,"the two new proposed methods are only aimed for hypothesis testing, not for causal effect size estimation. Time varying information not captured by single measurement. SNP weights may not be transferable from large to small population.","No validated methods at time of writing","Not discussed","Not discussed",NA,129
19,"no","yes","Mendelian randomization analysis of a time-varying exposure for binary disease outcomes using functional data analysis methods",2016,"Genetic Epidemiology","10.1002/gepi.22013","Cao","Peng Wei","pwei2@mdanderson.org","Department of Biostatistics, The University of Texas MD Anderson Cancer Center, 1400 Pressler St, Pickens Tower, FCT4.6044, Houston, TX 77030, USA","Effect of body mass index on type 2 diabetes and coronary artery disease","Method validation","One-sample","type 2 diabetes","type 2 diabetes","metabolic","Not discussed","Current study","25-75","both","171","1551",NA,NA,NA,"case/control","European","BMI","BMI","Guo 2013 BMI All ancestries both","18+","both","1722","108912","One-sample where they got exposure SNPs from external GWAS","Healthy","All ancestries","age, sex","Not discussed","Not discussed","Not discussed","Not discussed","Not discussed","Not discussed","Not discussed",NA,NA,"14","11","They say they used 14 SNPs from the GWAS by Guo et al but that GWAS only identified 11 so no idea where they got 3 extra SNPs from because there is no info","No",NA,"PACE+2SRI","Not discussed",NA,NA,NA,NA,"Not discussed","13.25","Not discussed","Not discussed","Not discussed","Not discussed","Not discussed","kg/m2","case/control",NA,"effect of the GRS on BMI increases slowly from age 25 to 50 years, followed by a slow decrease",NA,NA,NA,NA,"8.0000000000000002E-3",NA,NA,"the two new proposed methods are only aimed for hypothesis testing, not for causal effect size estimation. Time varying information not captured by single measurement. SNP weights may not be transferable from large to small population.","No validated methods at time of writing","Not discussed","Not discussed",NA,130
19,"no","yes","Mendelian randomization analysis of a time-varying exposure for binary disease outcomes using functional data analysis methods",2016,"Genetic Epidemiology","10.1002/gepi.22013","Cao","Peng Wei","pwei2@mdanderson.org","Department of Biostatistics, The University of Texas MD Anderson Cancer Center, 1400 Pressler St, Pickens Tower, FCT4.6044, Houston, TX 77030, USA","Effect of body mass index on type 2 diabetes and coronary artery disease","Method validation","One-sample","type 2 diabetes","type 2 diabetes","metabolic","Not discussed","Current study","25-75","both","171","1551",NA,NA,NA,"case/control","European","BMI","BMI","Guo 2013 BMI All ancestries both","18+","both","1722","108912","One-sample where they got exposure SNPs from external GWAS","Healthy","All ancestries","age, sex","Not discussed","Not discussed","Not discussed","Not discussed","Not discussed","Not discussed","Not discussed",NA,"14",NA,"11","They say they used 14 SNPs from the GWAS by Guo et al but that GWAS only identified 11 so no idea where they got 3 extra SNPs from because there is no info","No",NA,"PACE+2SRI","Not discussed",NA,NA,NA,NA,"Not discussed","13.25","Not discussed","Not discussed","Not discussed","Not discussed","Not discussed","kg/m2","case/control",NA,"subjects with more effect alleles have higher fitted BMI values across their lifetime",NA,NA,NA,NA,"2.5999999999999999E-2",NA,NA,"the two new proposed methods are only aimed for hypothesis testing, not for causal effect size estimation. Time varying information not captured by single measurement. SNP weights may not be transferable from large to small population.","No validated methods at time of writing","Not discussed","Not discussed",NA,131
19,"no","yes","Mendelian randomization analysis of a time-varying exposure for binary disease outcomes using functional data analysis methods",2016,"Genetic Epidemiology","10.1002/gepi.22013","Cao","Peng Wei","pwei2@mdanderson.org","Department of Biostatistics, The University of Texas MD Anderson Cancer Center, 1400 Pressler St, Pickens Tower, FCT4.6044, Houston, TX 77030, USA","Effect of body mass index on type 2 diabetes and coronary artery disease","Method validation","One-sample","type 2 diabetes","type 2 diabetes","metabolic","Not discussed","Current study","25-75","both","171","1551",NA,NA,NA,"case/control","European","BMI","BMI","Guo 2013 BMI All ancestries both","18+","both","1722","108912","One-sample where they got exposure SNPs from external GWAS","Healthy","All ancestries","age, sex","Not discussed","Not discussed","Not discussed","Not discussed","Not discussed","Not discussed","Not discussed",NA,NA,"14","11","They say they used 14 SNPs from the GWAS by Guo et al but that GWAS only identified 11 so no idea where they got 3 extra SNPs from because there is no info","No",NA,"PACE+2SFRI","Not discussed",NA,NA,NA,NA,"Not discussed","13.25","Not discussed","Not discussed","Not discussed","Not discussed","Not discussed","kg/m2","case/control",NA,"effect of the GRS on BMI increases slowly from age 25 to 50 years, followed by a slow decrease",NA,NA,NA,NA,"5.7000000000000002E-2",NA,NA,"the two new proposed methods are only aimed for hypothesis testing, not for causal effect size estimation. Time varying information not captured by single measurement. SNP weights may not be transferable from large to small population.","No validated methods at time of writing","Not discussed","Not discussed",NA,132
19,"no","yes","Mendelian randomization analysis of a time-varying exposure for binary disease outcomes using functional data analysis methods",2016,"Genetic Epidemiology","10.1002/gepi.22013","Cao","Peng Wei","pwei2@mdanderson.org","Department of Biostatistics, The University of Texas MD Anderson Cancer Center, 1400 Pressler St, Pickens Tower, FCT4.6044, Houston, TX 77030, USA","Effect of body mass index on type 2 diabetes and coronary artery disease","Method validation","One-sample","type 2 diabetes","type 2 diabetes","metabolic","Not discussed","Current study","25-75","both","171","1551",NA,NA,NA,"case/control","European","BMI","BMI","Guo 2013 BMI All ancestries both","18+","both","1722","108912","One-sample where they got exposure SNPs from external GWAS","Healthy","All ancestries","age, sex","Not discussed","Not discussed","Not discussed","Not discussed","Not discussed","Not discussed","Not discussed",NA,"14",NA,"11","They say they used 14 SNPs from the GWAS by Guo et al but that GWAS only identified 11 so no idea where they got 3 extra SNPs from because there is no info","No",NA,"PACE+2SFRI","Not discussed",NA,NA,NA,NA,"Not discussed","13.25","Not discussed","Not discussed","Not discussed","Not discussed","Not discussed","kg/m2","case/control",NA,"subjects with more effect alleles have higher fitted BMI values across their lifetime",NA,NA,NA,NA,"8.8999999999999996E-2",NA,NA,"the two new proposed methods are only aimed for hypothesis testing, not for causal effect size estimation. Time varying information not captured by single measurement. SNP weights may not be transferable from large to small population.","No validated methods at time of writing","Not discussed","Not discussed",NA,133
19,"no","yes","Mendelian randomization analysis of a time-varying exposure for binary disease outcomes using functional data analysis methods",2016,"Genetic Epidemiology","10.1002/gepi.22013","Cao","Peng Wei","pwei2@mdanderson.org","Department of Biostatistics, The University of Texas MD Anderson Cancer Center, 1400 Pressler St, Pickens Tower, FCT4.6044, Houston, TX 77030, USA","Effect of body mass index on type 2 diabetes and coronary artery disease","Method validation","One-sample","type 2 diabetes","type 2 diabetes","metabolic","Not discussed","Current study","25-75","both","171","1551",NA,NA,NA,"case/control","European","BMI","BMI","Guo 2013 BMI All ancestries both","18+","both","1722","108912","One-sample where they got exposure SNPs from external GWAS","Healthy","All ancestries","age, sex","Not discussed","Not discussed","Not discussed","Not discussed","Not discussed","Not discussed","Not discussed",NA,NA,"14","11","They say they used 14 SNPs from the GWAS by Guo et al but that GWAS only identified 11 so no idea where they got 3 extra SNPs from because there is no info","No",NA,"IV-outcome test","Not discussed",NA,NA,NA,NA,"Not discussed","13.25","Not discussed","Not discussed","Not discussed","Not discussed","Not discussed","kg/m2","case/control",NA,"effect of the GRS on BMI increases slowly from age 25 to 50 years, followed by a slow decrease",NA,NA,NA,NA,"2.5999999999999999E-2",NA,NA,"the two new proposed methods are only aimed for hypothesis testing, not for causal effect size estimation. Time varying information not captured by single measurement. SNP weights may not be transferable from large to small population.","No validated methods at time of writing","Not discussed","Not discussed",NA,134
19,"no","yes","Mendelian randomization analysis of a time-varying exposure for binary disease outcomes using functional data analysis methods",2016,"Genetic Epidemiology","10.1002/gepi.22013","Cao","Peng Wei","pwei2@mdanderson.org","Department of Biostatistics, The University of Texas MD Anderson Cancer Center, 1400 Pressler St, Pickens Tower, FCT4.6044, Houston, TX 77030, USA","Effect of body mass index on type 2 diabetes and coronary artery disease","Method validation","One-sample","type 2 diabetes","type 2 diabetes","metabolic","Not discussed","Current study","25-75","both","171","1551",NA,NA,NA,"case/control","European","BMI","BMI","Guo 2013 BMI All ancestries both","18+","both","1722","108912","One-sample where they got exposure SNPs from external GWAS","Healthy","All ancestries","age, sex","Not discussed","Not discussed","Not discussed","Not discussed","Not discussed","Not discussed","Not discussed",NA,"14",NA,"11","They say they used 14 SNPs from the GWAS by Guo et al but that GWAS only identified 11 so no idea where they got 3 extra SNPs from because there is no info","No",NA,"IV-outcome test","Not discussed",NA,NA,NA,NA,"Not discussed","13.25","Not discussed","Not discussed","Not discussed","Not discussed","Not discussed","kg/m2","case/control",NA,"subjects with more effect alleles have higher fitted BMI values across their lifetime",NA,NA,NA,NA,"3.3000000000000002E-2",NA,NA,"the two new proposed methods are only aimed for hypothesis testing, not for causal effect size estimation. Time varying information not captured by single measurement. SNP weights may not be transferable from large to small population.","No validated methods at time of writing","Not discussed","Not discussed",NA,135
26,"yes","yes","Causal relationships between obesity and the leading causes of death in women and men
",2019,"PLOS Genetics","10.1371/journal.pgen.1008405","Censin","Cecilia M Lindgren","lindgrenpa@bdi.ox.ac.uk","Big Data Institute at the Li Ka Shing Centre for Health Information and Discovery, University of Oxford, Oxford, United Kingdom, Wellcome Centre for Human Genetics, Nuffield Department of Medicine, University of Oxford, Oxford, United Kingdom, Program in Medical and Population Genetics, Broad Institute, Cambridge, Massachusetts, United States of America","Effect of body mass index on multiple disease outcomes","Previous studies have found causal relationships between higher BMI and WHR adjusted for BMI (WHRadjBMI) and type 2 diabetes (T2D) and coronary artery disease (CAD), using a limited number of previously known obesity-associated single nucleotide polymorphisms (SNPs). However, sex-specific relationships are largely unexplored as is the the role that obesity traits play in the leading causes of death beyond these cardiometabolic diseases.","One-sample","type 2 diabetes","type 2 diabetes","metabolic","Algorithm sorts participants to likely diabetes status by using information on e.g. self-reported diabetes diagnosis, age of diagnosis, medications, start of insulin within a year of diagnosis, and other self-reported data at the baseline visit. Outcome definition from Eastwood et al (28) algorithm. Probable and possible cases or probable only. Controls defined as diabetes unlikely.","Current study","40-69","both","18329","405178",NA,NA,NA,NA,"European","BMI","BMI","Pulit 2019 BMI European both","18+","both","Not discussed","806834",NA,"Healthy","European","Adjustments were made for baseline age, age2, array type, assessment centre, 10 principalcomponents, and sex if applicable, for all traits when in clinical units and for binary outcomes,and array and 10 principal components if rank inverse normal transformed (where adjustmentfor age, age2, assessment centre, and if applicable sex had already been performed in the rankinverse normal transformation of the residuals)","HRC","We then pruned these SNPs for LD independence, so that not correlated SNPs from different sex-specific analyses would be included, and to obtain a set of the same SNPs for all sex strata. Independent SNPs were selected by taking all the SNPs specified as “index” SNPs in the men, women or combined-sexes analyses and then keeping the SNP with the lowest combined-sexes P-value within each 1 Mb sliding window for BMI, WHR, and WHRadjBMI separately. We later excluded SNPs based on long-distance LD (r2>0.05)","Extensive re-analysis using differnet SNP sets and startification by smoking etc.","5x10-9","Not discussed","Not discussed","P >= 1x10-6",NA,NA,"565","806","Not all exclusions explained. For all GRSs, any SNPs found to be non-biallelic in the UK Biobank were excluded (n=6, rs7798002, rs73646205, rs10828247, rs10892873, rs699370, rs805768), as this would violate the additive assumption. Four SNPs were also excluded as they failed post-imputation quality control (rs11500477, rs144926207, rs547943994, rs9638713). To further ascertain that there was no LD between SNPs in a GRS, we computed the r2 between all pairs of SNPs included in an instrument–for pairs of correlated (r2>0.05) SNPs included in the same instrument, the SNP in each pair with the highest P-value was excluded (rs1025395, rs9302652, rs8189480).","Not discussed",NA,"Wald ratio","MR Egger","Weighted median",NA,NA,NA,"Consistent with main analysis: A few of the GRSs used in the main analysis showed evidence of directional pleiotropy in the MR-Egger intercept test. The MR-Egger point estimates for all these associations were of lower magnitude than the point estimates from the main MR analyses. Despite this, for all the disease outcome MR analyses where one sex had significantly higher estimates than the other the point estimates using the IVW, MR-Egger, and weighted median methods were all higher in the same sex as in the main analysis. This indicates that the sex differences we see are robust using different MR methods to compute causal estimates","Lowest F stat of any GRS was 4,921. We assessed the strengths of associations between the GRSs and their respective obesity trait by computing trait variance explained and the F-statistics. First, we standardized the obesity traits by rank inverse normal transformation of the residuals after regression of the obesity trait on baseline age, age2, assessment centre, and if applicable sex, after any sample quality exclusions. This was done separately for men and women in the sex-specific analyses, but jointly in the combined analyses. For WHRadjBMI, we also adjusted for BMI. We thereafter performed linear regression, adjusting for array type and 10 principal components. Trait variance explained was defined as the increase in adjusted R2 by inclusion of the GRS in the linear regression model. F-statistics were computed using the formula F=((n-k-1)/k)(R^2/〖1-R〗^2 ), where n is the number of observations, k=1 for number of instruments, and R2 the unadjusted R2","R","R package MendelianRandomization","Not discussed","Replicated in white british only subset. Consitent with main analysis","For the obesity trait-disease analyses, the P-value threshold was set at <0.001 (= 0.05/51) for the total of 51 obesity trait-disease combinations investigated in the study. For the obesitytrait-risk factor analyses, the P-value threshold was set at <0.003 (= 0.05/15), for the total of 15obesity trait-risk factor combinations investigated in the study.","SD","case/control","OR","3.18",NA,"95","2.97","3.39","<1.0x10-200","Bonferromi for 51 tests","9.8039215686274508E-4","imbalances in the proportion of women and men
in included studies, differential availability of summary-level sex-stratified GWAS data and
the potential for biases to operate differentially between women and men pose additional complexities in deciphering underlying causal effects. It is possible that our genetic instrument for WHRadjBMI might show features of colliderbias whereby SNPs included in the GRS associate with both higher WHR and lower BMI leading to potentially spurious findings. Sensitivity analysis supported main findings. Different SNPs and weightings for SNPs all supported main findings.","Performed extensive re-analysis using different SNP sets which were all consistent with main analysis","Results not generalizeable outside of Europeans. Recent studies have highlighted potential population stratification in both Genetic Investigation of ANthropometric Traits (GIANT) and UKBB. Another study has indicated that GRS distributions can differ slightly between different European populations. We therefore conducted analyses both in all Europeans (self-report of any “white” category) in the main analyses and in a subset of British participants only (in the “White British ancestry subset” as classified by the UK Biobank. The results were highly similar to those performed in all Europeans.","Samll case samples in cancers may have lead to weak power. In women, the effects of WHR were directionally consistent with harm, but the estimates were imprecise, probably reflecting insufficient powerin the sex-stratified analysis.",NA,381
26,"yes","yes","Causal relationships between obesity and the leading causes of death in women and men
",2019,"PLOS Genetics","10.1371/journal.pgen.1008405","Censin","Cecilia M Lindgren","lindgrenpa@bdi.ox.ac.uk","Big Data Institute at the Li Ka Shing Centre for Health Information and Discovery, University of Oxford, Oxford, United Kingdom, Wellcome Centre for Human Genetics, Nuffield Department of Medicine, University of Oxford, Oxford, United Kingdom, Program in Medical and Population Genetics, Broad Institute, Cambridge, Massachusetts, United States of America","Effect of body mass index on multiple disease outcomes","Previous studies have found causal relationships between higher BMI and WHR adjusted for BMI (WHRadjBMI) and type 2 diabetes (T2D) and coronary artery disease (CAD), using a limited number of previously known obesity-associated single nucleotide polymorphisms (SNPs). However, sex-specific relationships are largely unexplored as is the the role that obesity traits play in the leading causes of death beyond these cardiometabolic diseases.","One-sample","type 2 diabetes","type 2 diabetes","metabolic","Algorithm sorts participants to likely diabetes status by using information on e.g. self-reported diabetes diagnosis, age of diagnosis, medications, start of insulin within a year of diagnosis, and other self-reported data at the baseline visit. Outcome definition from Eastwood et al (28) algorithm. Probable and possible cases or probable only. Controls defined as diabetes unlikely.","Current study","40-69","male","11785","411722",NA,NA,NA,NA,"European","BMI","BMI","Pulit 2019 BMI European male","18+","male","Not discussed","374756",NA,"Healthy","European","Adjustments were made for baseline age, age2, array type, assessment centre, 10 principalcomponents, and sex if applicable, for all traits when in clinical units and for binary outcomes,and array and 10 principal components if rank inverse normal transformed (where adjustmentfor age, age2, assessment centre, and if applicable sex had already been performed in the rankinverse normal transformation of the residuals)","HRC","We then pruned these SNPs for LD independence, so that not correlated SNPs from different sex-specific analyses would be included, and to obtain a set of the same SNPs for all sex strata. Independent SNPs were selected by taking all the SNPs specified as “index” SNPs in the men, women or combined-sexes analyses and then keeping the SNP with the lowest combined-sexes P-value within each 1 Mb sliding window for BMI, WHR, and WHRadjBMI separately. We later excluded SNPs based on long-distance LD (r2>0.05)","Extensive re-analysis using differnet SNP sets and startification by smoking etc.","5x10-9","Not discussed","Not discussed","P >= 1x10-6",NA,NA,"220","243","Not all exclusions explained. For all GRSs, any SNPs found to be non-biallelic in the UK Biobank were excluded (n=6, rs7798002, rs73646205, rs10828247, rs10892873, rs699370, rs805768), as this would violate the additive assumption. Four SNPs were also excluded as they failed post-imputation quality control (rs11500477, rs144926207, rs547943994, rs9638713). To further ascertain that there was no LD between SNPs in a GRS, we computed the r2 between all pairs of SNPs included in an instrument–for pairs of correlated (r2>0.05) SNPs included in the same instrument, the SNP in each pair with the highest P-value was excluded (rs1025395, rs9302652, rs8189480).","Not discussed",NA,"Wald ratio","MR Egger","Weighted median",NA,NA,NA,"Consistent with main analysis: A few of the GRSs used in the main analysis showed evidence of directional pleiotropy in the MR-Egger intercept test. The MR-Egger point estimates for all these associations were of lower magnitude than the point estimates from the main MR analyses. Despite this, for all the disease outcome MR analyses where one sex had significantly higher estimates than the other the point estimates using the IVW, MR-Egger, and weighted median methods were all higher in the same sex as in the main analysis. This indicates that the sex differences we see are robust using different MR methods to compute causal estimates","Lowest F stat of any GRS was 4,921. We assessed the strengths of associations between the GRSs and their respective obesity trait by computing trait variance explained and the F-statistics. First, we standardized the obesity traits by rank inverse normal transformation of the residuals after regression of the obesity trait on baseline age, age2, assessment centre, and if applicable sex, after any sample quality exclusions. This was done separately for men and women in the sex-specific analyses, but jointly in the combined analyses. For WHRadjBMI, we also adjusted for BMI. We thereafter performed linear regression, adjusting for array type and 10 principal components. Trait variance explained was defined as the increase in adjusted R2 by inclusion of the GRS in the linear regression model. F-statistics were computed using the formula F=((n-k-1)/k)(R^2/〖1-R〗^2 ), where n is the number of observations, k=1 for number of instruments, and R2 the unadjusted R2","R","R package MendelianRandomization","Not discussed","Replicated in white british only subset. Consitent with main analysis","For the obesity trait-disease analyses, the P-value threshold was set at <0.001 (= 0.05/51) for the total of 51 obesity trait-disease combinations investigated in the study. For the obesitytrait-risk factor analyses, the P-value threshold was set at <0.003 (= 0.05/15), for the total of 15obesity trait-risk factor combinations investigated in the study.","SD","case/control","OR","2.79",NA,"95","2.58","3.03","5.7x10--135","Bonferromi for 51 tests","9.8039215686274508E-4","imbalances in the proportion of women and men
in included studies, differential availability of summary-level sex-stratified GWAS data and
the potential for biases to operate differentially between women and men pose additional complexities in deciphering underlying causal effects. It is possible that our genetic instrument for WHRadjBMI might show features of colliderbias whereby SNPs included in the GRS associate with both higher WHR and lower BMI leading to potentially spurious findings. Sensitivity analysis supported main findings. Different SNPs and weightings for SNPs all supported main findings.","Performed extensive re-analysis using different SNP sets which were all consistent with main analysis","Results not generalizeable outside of Europeans. Recent studies have highlighted potential population stratification in both Genetic Investigation of ANthropometric Traits (GIANT) and UKBB. Another study has indicated that GRS distributions can differ slightly between different European populations. We therefore conducted analyses both in all Europeans (self-report of any “white” category) in the main analyses and in a subset of British participants only (in the “White British ancestry subset” as classified by the UK Biobank. The results were highly similar to those performed in all Europeans.","Samll case samples in cancers may have lead to weak power. In women, the effects of WHR were directionally consistent with harm, but the estimates were imprecise, probably reflecting insufficient powerin the sex-stratified analysis.",NA,382
26,"yes","yes","Causal relationships between obesity and the leading causes of death in women and men
",2019,"PLOS Genetics","10.1371/journal.pgen.1008405","Censin","Cecilia M Lindgren","lindgrenpa@bdi.ox.ac.uk","Big Data Institute at the Li Ka Shing Centre for Health Information and Discovery, University of Oxford, Oxford, United Kingdom, Wellcome Centre for Human Genetics, Nuffield Department of Medicine, University of Oxford, Oxford, United Kingdom, Program in Medical and Population Genetics, Broad Institute, Cambridge, Massachusetts, United States of America","Effect of body mass index on multiple disease outcomes","Previous studies have found causal relationships between higher BMI and WHR adjusted for BMI (WHRadjBMI) and type 2 diabetes (T2D) and coronary artery disease (CAD), using a limited number of previously known obesity-associated single nucleotide polymorphisms (SNPs). However, sex-specific relationships are largely unexplored as is the the role that obesity traits play in the leading causes of death beyond these cardiometabolic diseases.","One-sample","type 2 diabetes","type 2 diabetes","metabolic","Algorithm sorts participants to likely diabetes status by using information on e.g. self-reported diabetes diagnosis, age of diagnosis, medications, start of insulin within a year of diagnosis, and other self-reported data at the baseline visit. Outcome definition from Eastwood et al (28) algorithm. Probable and possible cases or probable only. Controls defined as diabetes unlikely.","Current study","40-69","female","6544","416963",NA,NA,NA,NA,"European","BMI","BMI","Pulit 2019 BMI European female","18+","female","Not discussed","434794",NA,"Healthy","European","Adjustments were made for baseline age, age2, array type, assessment centre, 10 principalcomponents, and sex if applicable, for all traits when in clinical units and for binary outcomes,and array and 10 principal components if rank inverse normal transformed (where adjustmentfor age, age2, assessment centre, and if applicable sex had already been performed in the rankinverse normal transformation of the residuals)","HRC","We then pruned these SNPs for LD independence, so that not correlated SNPs from different sex-specific analyses would be included, and to obtain a set of the same SNPs for all sex strata. Independent SNPs were selected by taking all the SNPs specified as “index” SNPs in the men, women or combined-sexes analyses and then keeping the SNP with the lowest combined-sexes P-value within each 1 Mb sliding window for BMI, WHR, and WHRadjBMI separately. We later excluded SNPs based on long-distance LD (r2>0.05)","Extensive re-analysis using differnet SNP sets and startification by smoking etc.","5x10-9","Not discussed","Not discussed","P >= 1x10-6",NA,NA,"278","306","Not all exclusions explained. For all GRSs, any SNPs found to be non-biallelic in the UK Biobank were excluded (n=6, rs7798002, rs73646205, rs10828247, rs10892873, rs699370, rs805768), as this would violate the additive assumption. Four SNPs were also excluded as they failed post-imputation quality control (rs11500477, rs144926207, rs547943994, rs9638713). To further ascertain that there was no LD between SNPs in a GRS, we computed the r2 between all pairs of SNPs included in an instrument–for pairs of correlated (r2>0.05) SNPs included in the same instrument, the SNP in each pair with the highest P-value was excluded (rs1025395, rs9302652, rs8189480).","Not discussed",NA,"Wald ratio","MR Egger","Weighted median",NA,NA,NA,"Consistent with main analysis: A few of the GRSs used in the main analysis showed evidence of directional pleiotropy in the MR-Egger intercept test. The MR-Egger point estimates for all these associations were of lower magnitude than the point estimates from the main MR analyses. Despite this, for all the disease outcome MR analyses where one sex had significantly higher estimates than the other the point estimates using the IVW, MR-Egger, and weighted median methods were all higher in the same sex as in the main analysis. This indicates that the sex differences we see are robust using different MR methods to compute causal estimates","Lowest F stat of any GRS was 4,921. We assessed the strengths of associations between the GRSs and their respective obesity trait by computing trait variance explained and the F-statistics. First, we standardized the obesity traits by rank inverse normal transformation of the residuals after regression of the obesity trait on baseline age, age2, assessment centre, and if applicable sex, after any sample quality exclusions. This was done separately for men and women in the sex-specific analyses, but jointly in the combined analyses. For WHRadjBMI, we also adjusted for BMI. We thereafter performed linear regression, adjusting for array type and 10 principal components. Trait variance explained was defined as the increase in adjusted R2 by inclusion of the GRS in the linear regression model. F-statistics were computed using the formula F=((n-k-1)/k)(R^2/〖1-R〗^2 ), where n is the number of observations, k=1 for number of instruments, and R2 the unadjusted R2","R","R package MendelianRandomization","Not discussed","Replicated in white british only subset. Consitent with main analysis","For the obesity trait-disease analyses, the P-value threshold was set at <0.001 (= 0.05/51) for the total of 51 obesity trait-disease combinations investigated in the study. For the obesitytrait-risk factor analyses, the P-value threshold was set at <0.003 (= 0.05/15), for the total of 15obesity trait-risk factor combinations investigated in the study.","SD","case/control","OR","3.77",NA,"95","3.38","4.2","1.7x10-128","Bonferromi for 51 tests","9.8039215686274508E-4","imbalances in the proportion of women and men
in included studies, differential availability of summary-level sex-stratified GWAS data and
the potential for biases to operate differentially between women and men pose additional complexities in deciphering underlying causal effects. It is possible that our genetic instrument for WHRadjBMI might show features of colliderbias whereby SNPs included in the GRS associate with both higher WHR and lower BMI leading to potentially spurious findings. Sensitivity analysis supported main findings. Different SNPs and weightings for SNPs all supported main findings.","Performed extensive re-analysis using different SNP sets which were all consistent with main analysis","Results not generalizeable outside of Europeans. Recent studies have highlighted potential population stratification in both Genetic Investigation of ANthropometric Traits (GIANT) and UKBB. Another study has indicated that GRS distributions can differ slightly between different European populations. We therefore conducted analyses both in all Europeans (self-report of any “white” category) in the main analyses and in a subset of British participants only (in the “White British ancestry subset” as classified by the UK Biobank. The results were highly similar to those performed in all Europeans.","Samll case samples in cancers may have lead to weak power. In women, the effects of WHR were directionally consistent with harm, but the estimates were imprecise, probably reflecting insufficient powerin the sex-stratified analysis.",NA,383
34,"no","yes","BMI as a Modifiable Risk Factorfor Type 2 Diabetes: Refining andUnderstanding Causal EstimatesUsing Mendelian Randomization",2016,"Diabetes","10.2337/db16-0418","Corbin","Nicholas J. Timpson","n.j.timpson@bristol.ac.uk","MRC Integrative Epidemiology Unit, University of Bristol, Bristol, U.K.","Effect of body mass idnex on type 2 diabetes","The availability of multiple variants associated with BMI offers a new chance to resolve the true causal effect of BMI on type 2 diabetes","Two-sample summary-level","type 2 diabetes","type 2 diabetes","metabolic","Varied by cohort","Morris 2012 Type 2 Diabetes European/Pakistani both","40-70 (approx)","both","12171","56862","34840","114981","Unclear whether using one or two of the GWAS's in the external source: The DIAGRAM consortium produced two GWAS and combined them","Healthy","European/Pakistani","BMI","BMI","Locke 2015 BMI European adults both","both",NA,"189079","322154","To avoid sample overlap, GIANT estimates were recalculated in the absence of DIAGRAM cohorts, yielding a maximum sample size at any given locus of 189,079.","Healthy","European",NA,NA,"Not discussed","Not discussed","5×10−8","Not discussed","Not discussed","Not discussed",NA,"96",NA,"77","Say they use EU SNPs but quote All ancestries SNP number. Of the all anestries SNPs, all but one (rs4787491, INO80E) of the BMI-associated SNPs (P , 5 3 1028) from GIANT had results listed in the DIAGRAMv3 data set so 96 SNPs with results in both data sets were taken forward for analysis.","Not discussed",NA,"Inverse variance weighted","MR Egger","Weighted median","Cook's distance","Re-ran analyses after excluding potentially pleiotropic snps","SIMEX - and biased adjusted causal effect estimation","Consistent with main analysis","Not discussed","R","Not discussed","Not discussed","Not discussed","Not discussed","SD","Case/control status","OR","1.2",NA,NA,"1.0900000000000001","1.3","8.00 x 10-5","None",NA,"No major limitations mentioned","In this example, the use of recently derived methods (9,11) designed to overcome problems caused by directional pleiotropy yields estimates that are more stable in the presence or absence of potentially invalid instruments and confirm the likely magnitude of the average effect of BMI on type 2 diabetes","Not discussed","Not discussed",NA,584
35,"no","yes","Causal Associations of Adiposity and Body Fat Distribution with Coronary Heart Disease, Stroke Subtypes and Type 2 Diabetes: A Mendelian Randomization Analysis",2017,"Circulation","10.1161/CIRCULATIONAHA.116.026560","Dale","Caroline E Dale","ku.ca.lcu@elad.c","Farr Institute of Health Informatics Research, UCL Institute of Health Informatics, University College London, 222 Euston Road, London, NW1 2DA, United Kingdom","Effect of body mass index and waist hip ratio adjusted for body mass idnex on cardiometabolic traits","Implications of different adiposity measures on cardiovascular disease aetiology remain unclear","one-sample meta-analysis","type 2 diabetes","type 2 diabetes","metabolic","Defined in individual GWASs","Current study","63.5 (mean)","both","34840","149821",NA,NA,NA,"Healthy","European","BMI","BMI","Locke 2015 BMI All ancestries both",NA,NA,"339224","339224",NA,"Healthy","European (Individuals of non-European ancestry were removed to minimise confounding by population structure.)","Not discussed","Defined in individual cohorts","Not discussed","Linear and logistic models with confounders","5×10−8","Not discussed","LD R2 > 0.8","Yes",NA,"97",NA,"97",NA,"Yes","Power to detect causal estimates was calculated based on the proportion of variance of the exposure explained by the instruments (R2), the total number of individuals in the analysis, and the number of cases and controls using the online tool http://cnsgenomics.com/shiny/mRnd/32.","Inverse variance weighted (fixed effects)","MR Egger","Weighted median",NA,NA,NA,"Consistent with main analysis","R2 1.7%","Stata version 14","mrrobust","Not discussed","Not discussed","Correction for two exposures P < 0.025","SD","Case/control","OR","1.98",NA,"95","1.41","2.78","Not discussed","None",NA,"Limitations include the potential pleiotropic effects of the multi-SNP instruments. However, results suggest little evidence for unbalanced pleiotropy","With multi-SNP instruments, there is a chance that pleiotropic effects might become balanced such that causal inference regarding the exposure is possible. In this study we perform MR analyses of BMI and WHR together with recently developed methods that are robust to horizontal pleiotropy under additional assumptions. We therefore employ MR-Egger regression to provide a test for unbalanced pleiotropy and a causal estimate of exposure on outcome in its presence10, 11. In addition we use the weighted median estimator which can give valid estimates even in the presence of horizontal pleiotropy provided at least 50 per cent of the information in the analysis comes from variants that are valid instruments, and has the advantage of retaining greater precision in the estimates compared to MR-Egger12.","Not discussed",NA,"Performed MVMR as sensitivity: We found some evidence for association of both adiposity instruments with smoking, but not with other major confounders (Supplemental Table 16). To account for this, sensitivity analyses were undertaken for each cardiometabolic disease using multivariate MR including the effect of each SNP used as instrument for BMI and WHRadjBMI on smoking. MR estimates were found to be robust to this adjustment",626
48,"no","yes","The Role of Adiposity in Cardiometabolic Traits: A
Mendelian Randomization Analysis",2013,"PLOS Medicine","10.1371/journal.pmed.1001474","Fall","Erik Ingelsson","erik.ingelsson@medsci.uu.se","Molecular Epidemiology and Science for Life Laboratory, Department of Medical Sciences, Uppsala University, Uppsala, Sweden","Effect of body mass index on cardiometabolic traits","The association between adiposity and cardiometabolic traits is well known from epidemiological studies. Whilst the causal relationship is clear for some of these traits, for others it is not.","one-sample meta-analysis","type 2 diabetes","type 2 diabetes","metabolic","Fasting blood glucose ≥7 mmol/L or anti-diabetic treatment. Self-reported diabetes","Current study","18+","Both","20804","139543",NA,NA,NA,"Healthy","European","BMI","BMI","Current study","18+","Both","160347",NA,NA,"Healthy","European","Age, Sex","Whenever rs9939609 was not genotyped directly, we used either (i) the HapMap II CEU (European) reference panel–imputed genetic information from genome-wide association studies (http://hapmap.ncbi.nlm.nih.gov/downloads/genotypes/2008-10_phaseII/) for rs9939609 (n = 5) or (ii) genotype information from a predefined list of proxies that are in high linkage disequilibrium (LD) with rs9939609 (n = 10, r2>0.9; Table S3)",NA,"Not discussed","Not discussed",NA,"R2 > 0.9","p>0.0001","FTO (rs9939609)",NA,NA,NA,NA,"No",NA,"Inverse variance weighted (multiplicative random effects)","Not discussed",NA,NA,NA,NA,"Observational estimates were similar","Not discussed","Varied by cohort but  at least one cohort used PLINK, R, SPSS, STATA","Not discussed","Not discussed","Not discussed","No","kg/m2","Case/control","Odds ratio","1.3660000000000001",NA,"95","1.234","1.5129999999999999","2.0x10-9","None",NA,"The limitations of our study are tied to the validity of the assumptions underlying causal interpretation within MR studies.","the precise mechanism of the FTO polymorphisms is still unclear, and potential pleiotropy cannot completely be ruled out","all studies included only individuals of European ancestry. Hence, bias from population stratification is deemed unlikely","Post hoc power calculation showed that for the binary traits with non-significant IVs (CHD, ischemic stroke, and all-cause stroke), we had an 80% chance of detecting an IV estimator odds ratio (OR) of 1.08–1.09/BMI unit or higher, and a 95% chance of detecting an OR of 1.13–1.15/BMI unit or higher.",NA,743
48,"no","yes","The Role of Adiposity in Cardiometabolic Traits: A
Mendelian Randomization Analysis",2013,"PLOS Medicine","10.1371/journal.pmed.1001474","Fall","Erik Ingelsson","erik.ingelsson@medsci.uu.se","Molecular Epidemiology and Science for Life Laboratory, Department of Medical Sciences, Uppsala University, Uppsala, Sweden","Effect of body mass index on cardiometabolic traits","The association between adiposity and cardiometabolic traits is well known from epidemiological studies. Whilst the causal relationship is clear for some of these traits, for others it is not.","one-sample meta-analysis","type 2 diabetes","incident","metabolic","Fasting blood glucose ≥7 mmol/L or anti-diabetic treatment. Self-reported diabetes","Current study","18+","Both","1991","29264",NA,NA,NA,"Healthy","European","BMI","BMI","Current study","18+","Both","31255",NA,NA,"Healthy","European","Age, Sex","Whenever rs9939609 was not genotyped directly, we used either (i) the HapMap II CEU (European) reference panel–imputed genetic information from genome-wide association studies (http://hapmap.ncbi.nlm.nih.gov/downloads/genotypes/2008-10_phaseII/) for rs9939609 (n = 5) or (ii) genotype information from a predefined list of proxies that are in high linkage disequilibrium (LD) with rs9939609 (n = 10, r2>0.9; Table S3)",NA,"Not discussed","Not discussed",NA,"R2 > 0.9","p>0.0001","FTO (rs9939609)",NA,NA,NA,NA,"No",NA,"Inverse variance weighted (multiplicative random effects)","Not discussed",NA,NA,NA,NA,"Observational estimates were similar","Not discussed","Varied by cohort but  at least one cohort used PLINK, R, SPSS, STATA","Not discussed","Not discussed","Not discussed","No","kg/m2","Case/control","Hazard ratio","1.347",NA,"95","1.123","1.6160000000000001","1E-3","None",NA,"The limitations of our study are tied to the validity of the assumptions underlying causal interpretation within MR studies.","the precise mechanism of the FTO polymorphisms is still unclear, and potential pleiotropy cannot completely be ruled out","all studies included only individuals of European ancestry. Hence, bias from population stratification is deemed unlikely","Post hoc power calculation showed that for the binary traits with non-significant IVs (CHD, ischemic stroke, and all-cause stroke), we had an 80% chance of detecting an IV estimator odds ratio (OR) of 1.08–1.09/BMI unit or higher, and a 95% chance of detecting an OR of 1.13–1.15/BMI unit or higher.",NA,744
52,"no","yes","Childhood BMI and Adult Type 2 Diabetes, Coronary Artery Diseases, Chronic Kidney Disease, and Cardiometabolic Traits: A Mendelian Randomization Analysis",2018,"Diabetes Care","10.2337/dc17-2141","Geng","Tao Huang","huangtao@bjmu.edu.cn","Epidemiology Domain, Saw Swee Hock School of Public Health, National University of Singapore, Singapore","Effect of childhood body mass index on adult cardiometabolic traits","Compelling observational studies have documented that higher BMI during childhood is associated with an increased risk of cardiometabolic morbidities such as coronary artery disease (CAD), type 2 diabetes, hypertension, and dyslipidemia in adult life (4–6), as well as the adult levels of insulin, lipids, and systolic blood pressure (7). However, both socioeconomic status and unmeasured lifestyle factors might confound these observational associations. Therefore, the causality of these observations remains unclear.
Identifying a potentially causal effect of childhood obesity on later life disease development could help guide prevention efforts.","Two-sample summary-level","type 2 diabetes","type 2 diabetes","metabolic","Type 2 Diabetes","Mahajan 2014 T2D Trans-ethnic both","18+","both","26488","83964","26488","83964",NA,"Healthy","Trans-ethnic","BMI","childhood","Felix 2016 BMI, childhood European both","3-10","both","35668","35668",NA,"Healthy","European","Not discussed","Not discussed","R2 >= 0.05 (We assessed correlation linkage disequilibrium (LD) between the 15 childhood BMI SNPs and sentinel SNPs associated with all outcomes. . . When the correlation coefficient between SNPs was high (r2 >= 0.05), we discarded the SNP with the larger P value)","Not discussed","5x10-8","Not discussed","Not discussed","Not discussed",NA,NA,"15","15",NA,"Not discussed",NA,"Inverse variance weighted","Simple median","Weighted median","MR Egger",NA,NA,"Consistent with main analysis","No direct assessment, but they do say ""The MR-Egger regression test was used to evaluate the directional pleiotropy and investigate the null causal hypothesis under the InSIDE (Instrument Strength Independent of Direct Effect) assumption""","Stata version 13;R version 3.2.3","Not discussed","Not discussed","Not discussed","Not discussed","SD (increase)","Case/control","OR","1.83",NA,"95","1.46","2.2999999999999998","2.5x10-7","None",NA,"we assumed that the associations between childhood BMI and all outcomes are linear. possible that our findings reflect a shared genetic basis between childhood BMI and cardiometabolic diseases rather than a causal relationship. genetic variants influencing childhood BMI may also influence adult BMI; therefore, it is difficult to specify when these effects happen. there would be some overlap between the genetic variants related to childhood BMI versus adult BMI. Although adult BMI is not strictly a confounder, 12 of the 15 SNPs for childhood BMI are also reported signals for adulthood. Further investigations on the timing of the exposure are warranted. Finally, we cannot directly assess whether population stratification and other potential confounders may be influencing our results; residual and unmeasured confounding might remain.","The MREgger regression showed that the estimated intercept term was centered at the origin with a CI including the null, suggesting that our results were not being influenced by pleiotropy","we cannot directly assess whether population stratification may influence our results","The large sample size allowed us to assess the consistency of associations across different methods and to gain sufficient power for reliable estimation of causal effects.",NA,940
63,"no","yes","Causal effects of cardiovascular risk factors on onset of major age-related diseases: A time-to-event Mendelian randomization study",2017,"Experimental Gerontology","10.1016/j.exger.2017.09.019","He","Liang He","lianghe@mit.edu","Erwin Mill Building, 2024 W. Main St., Durham, NC 27705, USA","Effect of BMI on age related diseases","Elucidating the causal effects of common intermediate risk factors on the onset of age-related diseases is indispensable for developing prevention and intervention procedures.","One-sample","type 2 diabetes","type 2 diabetes","metabolic","Defined in individual cohorts","Current study","Mean 35.91-72.41","both","30505",NA,"30505",NA,NA,"Healthy","non-Hispanic Caucasian","BMI","BMI","Speliotes 2010 BMI Europeans both","Mean 35.91-72.41","both","30505","249796","One-sample where they got exposure SNPs from external GWAS","Healthy","European","Not discussed","1000 Genomes Project Phase I reference panel","Not discussed","Not discussed","5x10-8","Not discussed","Not discussed","Hardy-Weinberg equilibrium test p < 1e−05",NA,NA,"32","32",NA,"No",NA,"Time-to-event MR","MR Egger",NA,NA,NA,NA,"Also conducted sensitivity analyses: Leave-one out, plus analysis where birth cohort, sex, education level, smoking and alcohol consumption history up to the enrollment were included as covariates","Polygenic score was significantly (p < 0.05) as- sociated with its risk factor","Not discussed","Not discussed","Not discussed","Performed cohort specific MR plus MR on meta-analysed cohorts","Not discussed",NA,NA,"Additive hazards model","0.00088","2.6200000000000003E-4",NA,NA,NA,"1.4899999999999999E-4",NA,NA,"The definitions of the diseases and criteria of diagnosis may vary across these five cohorts","Some observed causal associations can be attributed to pleiotropic effects of some genetic variations","Not discussed","the constructed polygenic scores can only explain a small proportion of the variance of the intermediate risk factors, which may limits the statistical power to detect the causal effects, the numbers of cases for some diseases are small, so there might be no sufficient statistical power to detect the causal effect for these diseases.",NA,1149
65,"no","yes","Causal Effects of Body Mass Index
on Cardiometabolic Traits and Events: A Mendelian Randomization Analysis",2014,"The American Journal of Human Genetics","10.1016/j.ajhg.2013.12.014","Holmes","Michael V. Holmes,","michael.holmes@uphs.upenn.edu","Division of Transplantation, Department of Surgery, Perelman School of Medicine, University of Pennsylvania, 3400 Spruce Street, Philadelphia, PA 19104, USA; Genetic Epidemiology Group, Institute of Cardiovascular Science, Faculty of Population Health Sciences, University College London, 1–19 Torrington Place, London WC1E 6BT, UK","Effect of BMI on cardiometabolic traits and events","Elevated body mass index associates with cardiometabolic traits on observational analysis, yet the underlying causal relationships remain unclear.","One-sample","type 2 diabetes","type 2 diabetes","metabolic","Defined in individual cohorts","Current study","18+","both","4407","31844",NA,NA,NA,"Healthy","Manually fill","BMI","BMI","Guo 2013 BMI All ancestries both","18+","both","36251","108912","One-sample where they got exposure SNPs from external GWAS","case/control","European","Not discussed","Not discussed","Not discussed","We also investigated the association between the GS and the traditional confounders age, gender, and smoking status.","2.4x10-6","Not discussed","Not discussed","Not discussed",NA,NA,"14","11","Not discussed","Not discussed",NA,"Logistic control function estimator","Not discussed",NA,NA,NA,NA,"Sensitivity analysis for pleiotropic effects - but not frmal method, rather SNP lists and associations tested","F statistic (>10); r2 (0.8%)","STATA","ivreg","Not discussed","Not discussed","Not discussed","kg/m2","case/control","OR","1.27",NA,"95","1.18","1.36",NA,NA,NA,"Our instrumental variable (causal) analysis made the assumption of a linear relationship14 between BMI and cardiometabolic traits and events. This is at odds with some published observa- tional studies","In support of our data is the concordance between our Mendelian randomized estimates for all traits (including CHD) and the clinical-trial randomized estimates from the LOOK AHEAD trial.
SNPs specific to refined adiposity phenotypes. Studies
included in this analysis contributed to the original dis-
covery analysis,23 and thus use of overlapping studies for
discovery and Mendelian randomization analysis could
theoretically result in model overfitting. Our instrumental
variable (causal) analysis made the assumption of a linear
relationship14 between BMI and cardiometabolic traits
and events. This is at odds with some published observa-
4
intervention on risk of T2D.
When we compared the estimates from the instru-
the Look AHEAD trial","We restricted our analysis to individuals of European ancestry to avoid confounding by population admixture.","not discussed",NA,1174
90,"no","yes","Association of Body Mass Index With Cardiometabolic Disease in the UK Biobank",2016,"JAMA Cardiology","10.1001/jamacardio.2016.5804","Lyall","Donald M. Lyall","donald.lyall@glasgow.ac.uk","Institute of Health and Wellbeing, University of Glasgow, 1 Lilybank Gardens, Glasgow G12 8RZ, Scotland","Effect of body mass index on cardiometabolic diseases/traits","Higher body mass index (BMI) is a risk factor for cardiometabolic disease; however, the underlying causal associations remain unclear.","One-sample","type 2 diabetes","type 2 diabetes","metabolic","Participants were asked whether their physician had diagnosed them with diabetes (a minority may have had type 1 rather than type 2). They excluded individuals who had missing data for this question","Current study","37-73","both","6290","113569",NA,NA,NA,"Case/control","White Europeans","BMI","BMI","Locke 2015 BMI All ancestries both","Age range in Locke et al paper is 11-108","both","339224","339224",NA,"Healthy","Europeans","assessment centre, age, sex, genetic batch effect, array and stratification with 10 principal components","Not discussed","Not discussed","Not discussed","Not discussed","Not discussed","Not discussed","Yes",NA,NA,"93","97","95 genotyped and 2 not in HWE","Not discussed",NA,"Two-stage-least-squares","MR Egger",NA,NA,NA,NA,"Consistent with main analysis: Note that they said that they visually looked for outliers on the snp-exposure/snp-outcome scatter plot to see if there were any outliers. They said there was one for each of t2d and both blood pressure. However ""results were unchanged when these outliers were removed and, for simplicity, we report estimates derived using all 93 SNPs""","F-statistic","Stata version 13","ivreg2","Not discussed","Not discussed","Yes - the authors stated ""All statistical tests were 2-sided and P<0.01 was chosen as we had multiple outcomes; formal correction for type 1 error can be overly conservative when testing intercorrelated outcomes"" but they don't show any correlations between outcomes or justify the choice of 0.01 any further than that statement","SD","case/control","OR","2.75",NA,"95","2.2400000000000002","3.37","3.9x10-22","Not fully explained",NA,"We found a small but significant correlation between the PGR score and higher rates of smoking, alcohol intake, and Townsend deprivation scores and thus made additional adjustments for these factors in our analyses, which did notalter the estimates we obtained.","Whether these associations represent vertical or horizontal pleiotropy remains unknown. The present sample also lacks data on a complete repertoire of potential mediators, such as lipid traits and glucose levels; these data will be available in the full UK Biobank in the next few years.","There may be a degree of selection bias in the sense that less physically and cognitively impaired individuals responded to theUKBiobank invitation and attended the assessment. The UK Biobank cohort is representative of the UK population in terms of some characteristics, such as age, sex, ethnicity, and deprivation, but not necessarily all (eg,someparticipants are less likely tosmoke and drink alcohol regularly).","Because MR-Egger is inherently more conservative, potentially meaningful causal associations might not be identified (type II error). Furthermore, this approach may be inadequately powered to detect pleiotropy when it is present.","Note: it's unclear how many individuals were used as controls, as the authors only state the number of cases and not the number of controls or not how many individuals overlapped between the four binary outcomes (i.e., stroke, CHD, hypertension and T2D). One note is that they state that they used 97 variants from the study of 339224 individuals of EUROPEAN descent. So actually unclear as to whether they used the European adults one or the all ancestries results. Note that the authors also did an adjusted model for townsend deprivation score, smoking and alcohol.  The results didn't really change when adding these (the betas attenuated slightly with some and inflated in others but confidence intervals all overlapped).",1350
95,"no","yes","Causal Associations in Type 2 Diabetes Development",2019,"J Clin Endocrinol Metab","10.1210/jc.2018-01648","Marott","Marianne Benn","Marianne.Benn@regionh.dk.","Department of Clinical Biochemistry, Rigshospitalet, Blegdamsvej 9, Copenhagen Ø 2100, Denmark","Effect of body mass index on type 2 diabetes","Obesity, glucose, insulin resistance [homeostatic model assessment, version 2, for insulin resistance (HOMA2-IR)], and insulin secretion (HOMA2-b) have been associated with type 2 diabetes (T2D) observationally.","One-sample","type 2 diabetes","type 2 diabetes","metabolic","Hospital admissions and diagnoses entered in the national Danish Patient Registry and all causes of death in the Danish Causes of Death Registry with information on a diagnosis of type 2 diabetes according to the WHO, ICD 8th and 10th edition. Diagnosis of type 2 diabetes requried a plasms glucose or hemoglobin A1c level according to the changing diagnostic critera over time.","Current study","20-100 years","both","3776","93091",NA,NA,"Unclear what the right numbers are","Healthy","Europeans - Copenhagen General Population Study","BMI","BMI","Current study","20-100","both","96867",NA,"Unclear what the right numbers are","Healthy","Europeans","Not discussed",NA,"Not discussed","Not discussed","Not discussed","Not discussed","Not discussed","Yes - Pearson's chi-squared test",NA,NA,"5","Not discussed - (SNPs in FTO, MC4R, TMEM18, BDNF, GNPDA2)","They just say that they used SNPs associated with BMI","Not discussed",NA,"Two-stage-least-squares","MR Egger",NA,NA,NA,NA,"They also checked association between the genetic variants and confounders, but do not discuss MR Egger results","Not discussed","Stata version 13.1","ivreg2","No - but they did do a one-sample and two-sample analysis so not much of a replication but validation","Not discussed","Not discussed","SD","Odds ratio of type 2 diabetes risk","OR","2.21",NA,"95","1.25","3.91","6.0000000000000001E-3","None",NA,"The potential limitations of the present study consequently included that only inpatients and outpatients with type 2 diabetes were included in the present study, excluding all patients with type 2 diabetes only seen by general practitioners. Despite this limitation of the observational estimates, the causal, genetic estimates will not be biased by the nonfasting state. The potential limitations of the Mendelian randomization design include pleitropy, selection bias, and population stratification. However, using multiple genetic polymorphisms acting independently and via different pathways to change the levels of BMI, glucose, C-peptide, HOMA2- IR index, and HOMA2-b percentage, which might be informative in understanding the etiology of type 2 diabetes and might highlight specific mechanisms to prioritize for pharmacological intervention in all available individuals from an ethnically homogenous white population, these potential limitations are likely to have been avoided.","Literally only said once (and spelt wrong!) - ""The potential limitations of the Mendelian randomization design include pleitropy…""","Literally only said once - ""The potential limitations of the Mendelian randomization design include… and population stratification"" and then mention that they used an ""ethnically homogenous white population""","Not mentioned","Worth noting that this is one of the only papers I've read so far that has checked for linearity in ordered groups using the Cuzick nonparametric extension of the Wilkcoxon rank sum test with groups of participants classified by alleles associated with BMI, glucose and C-peptide levels, HOMA2-IR index and HOMA2-B percentage were ranked according to changing levels and coded as 0,1,2,3 and so forth. This estimate was a similar magnitude and same direction as the observational analysis in the same paper (HR: 1.66; 95% CI: 1.62, 1.72; p=1x10e-188). Despite the fact that they perform a two-sample MR they only say ""The consortia data showed results similar to those from the data from the CGPS"" 0 they don't show results",1362
104,"no","yes","Body Mass Index and Risk of Alzheimer’s Disease: A Mendelian Randomization Study of 399,536 Individuals",2017,"Journal of Clinical Endocrinology and Metabolism","10.1210/jc.2017-00195","Nordestgaard","Ruth Frikke-Schmidt","ruth.frikke-schmidt@regionh.dk.","Department of Clinical Biochemistry, KB 3011, Rigshospitalet, Copenhagen University Hospital, Blegdamsvej 9, DK-2100 Copenhagen Ø, Denmark.","Effect of body mas index on Alzheimers disease","Recently, data on 2,000,000 people established that low body mass index (BMI) is associated
with increased risk of dementia. Whether this observational association reflects a causal
effect remains to be clarified.","One-sample","type 2 diabetes","type 2 diabetes","metabolic","Information on diagnoses of type 2
diabetes (World Health Organization; ICD-8 250; and ICD-
10, E11 E13 and E14) was collected similarly, and was used
as a positive control. Follow up began at the time of blood
sampling (observational analyses) or at the establishment of
the national Danish Patient Registry (January 1st, 1977) or on
the birthday of the participant, whichever came later (genetic
analyses).","Current study","20-100+","both","3281","92297",NA,NA,NA,"Healthy","European","BMI","BMI","Speliotes 2010 BMI Europeans both","Age range in the Speliotes paper is 14-108","both","249796","249796",NA,"Healthy","European","age and sex",NA,"Not discussed","Not discussed","Not discussed","Not discussed","Not discussed","Chi-square",NA,NA,"5","32","Chose the top 5 striongest SNPs","Not discussed",NA,"Two-stage-least-squares",NA,NA,NA,NA,NA,"This was a ""positive control"" to examine the association between BMI and Alzheimer's disease (previous two rows)","F-statistic","Stata","ivreg2 and ivpois","Not discussed","Not discussed","Not discussed","1kg/m2 lower BMI","Odds ratio for risk of Type 2 Diabetes","OR","0.77",NA,"95","0.61","0.98","0.82",NA,NA,"The reason for this is that the associations of the genetic variants with BMI are relatively small, and therefore, large numbers of cases
and controls are required to reliably preclude any causal relation. A limitation
could be the observation that genetically low BMI is associated with low risk of hypertension. This is expected, as a causal relationship exists between high BMI and hypertension (36). However, because genetically low BMI is associated with low risk of hypertension, and because low risk of hypertension is associated with low risk of Alzheimer’s disease, these associations cannot explain the present observational relation between low BMI and high risk of Alzheimer’s disease.","Not discussed","They mention that their findings are based in a large homogenous population such that they can control for a number of important confounders and they included a positive control","Not discussed","This is the weighted allele score group and the resul using the simple unweighted score is similar",1482
129,"no","yes","Associations of obesity and circulating
 insulin and glucose with breast cancer risk:
 a Mendelian randomization analysis",2018,"International Journal of Epidemiology","10.1093/ije/dyy201","Shu","Wei Zheng","wei.zheng@vanderbilt.edu","Vanderbilt Epidemiology Center and Vanderbilt-Ingram Cancer Center, Vanderbilt University School of Medicine, 2525 West End Avenue, 8th Floor, Nashville, TN 37203-1738, USA","Effect of adiposity measures on type 2 diabetes and breast cancer","In addition to the established association between general obesity and
breast cancer risk, central obesity and circulating fasting insulin and glucose have been
linked to the development of this common malignancy. Findings from previous studies,
however, have been inconsistent, and the nature of the associations is unclear.","Two-sample summary-level","type 2 diabetes","type 2 diabetes","metabolic","Varied by cohort","Morris 2012 Type 2 Diabetes European/Pakistani both","40-70 (approx)","both","34840","114981","34840","114981",NA,"case/control","European/Pakistani","BMI","BMI","Not discussed","Not discussed","Not discussed","Not discussed","Not discussed","SNPs were selected from multiple studies by searching the National Human Genome Research Institute-European Bioinformatics Institute Catalogof Published Genome-Wide Association Studies and the literaturefor SNPs associated with the following traits: levels of2-h glucose (2hrGlu), fasting glucose (FG), fasting insulin(FI), BMI and waist-hip-ratio with adjustment of BMI(WHRadj BMI).","Not discussed","European","Not discussed","Not discussed","r2 < 0.1","Not discussed","4.9999999999999998E-8","Not discussed","Not discussed","Not discussed",NA,"132",NA,NA,"SNPs were selected from multiple studies by searching the National Human Genome Research Institute-European Bioinformatics Institute Catalogof Published Genome-Wide Association Studies and the literaturefor SNPs associated with the following traits: levels of2-h glucose (2hrGlu), fasting glucose (FG), fasting insulin(FI), BMI and waist-hip-ratio with adjustment of BMI(WHRadj BMI).","Not discussed",NA,"Inverse variance weighted","MR Egger",NA,NA,NA,NA,NA,"No","R","Not discussed","Not discussed","Not discussed","Not discussed","kg/m2","Case/control","OR","1.92",NA,"95","1.64","2.25","2.8599999999999999E-13",NA,NA,"Pleiotropy effect exist in obesity association studies; statistical power might be low because of low variance explained by IVs.","Pleiotropy was found for the associations of obesity, but it is not likely that the observed associations can be primarily explained by pleiotropic effects.","Not discussed","Our ability to perform Mendelianrandomization analysis is limited by the genetic variants identified to date in GWAS, and the variance explained bythese genetic variants for some traits is small. We used 10 instruments in our main analysis, which could lead to false positive findings due to multiple comparisons. However, the associations reported in this study for 2-h glucose, fastinginsulin, BMI and WHRadj BMI were robust, reaching thestringent Bonferroni corrected significance level (P < 0.005).",NA,1603
129,"no","yes","Associations of obesity and circulating
 insulin and glucose with breast cancer risk:
 a Mendelian randomization analysis",2018,"International Journal of Epidemiology","10.1093/ije/dyy201","Shu","Wei Zheng","wei.zheng@vanderbilt.edu","Vanderbilt Epidemiology Center and Vanderbilt-Ingram Cancer Center, Vanderbilt University School of Medicine, 2525 West End Avenue, 8th Floor, Nashville, TN 37203-1738, USA","Effect of adiposity measures on type 2 diabetes and breast cancer","In addition to the established association between general obesity and
breast cancer risk, central obesity and circulating fasting insulin and glucose have been
linked to the development of this common malignancy. Findings from previous studies,
however, have been inconsistent, and the nature of the associations is unclear.","Two-sample summary-level","type 2 diabetes","type 2 diabetes","metabolic","Varied by cohort","Morris 2012 Type 2 Diabetes European/Pakistani both","40-70 (approx)","both","34840","114981","34840","114981",NA,"case/control","European/Pakistani","BMI","excluded pleiotropic SNPs","Not discussed","Not discussed","Not discussed","Not discussed","Not discussed","SNPs were selected from multiple studies by searching the National Human Genome Research Institute-European Bioinformatics Institute Catalogof Published Genome-Wide Association Studies and the literaturefor SNPs associated with the following traits: levels of2-h glucose (2hrGlu), fasting glucose (FG), fasting insulin(FI), BMI and waist-hip-ratio with adjustment of BMI(WHRadj BMI). SNPs for each trait excluded pleiotropic SNPs and the SNPs associated with the other four traits of interest.","Not discussed","European","Not discussed","Not discussed","r2 < 0.1","Not discussed","4.9999999999999998E-8","Not discussed","Not discussed","Not discussed",NA,"128",NA,NA,"SNPs were selected from multiple studies by searching the National Human Genome Research Institute-European Bioinformatics Institute Catalogof Published Genome-Wide Association Studies and the literaturefor SNPs associated with the following traits: levels of2-h glucose (2hrGlu), fasting glucose (FG), fasting insulin(FI), BMI and waist-hip-ratio with adjustment of BMI(WHRadj BMI). SNPs for each trait excluded pleiotropic SNPs and the SNPs associated with the other four traits of interest.","Not discussed",NA,"Inverse variance weighted","MR Egger",NA,NA,NA,NA,NA,"No","R","Not discussed","Not discussed","Not discussed","Not discussed","kg/m2","Case/control","OR","2.37",NA,"95","1.99","2.82","2.3999999999999999E-17",NA,NA,"Pleiotropy effect exist in obesity association studies; statistical power might be low because of low variance explained by IVs.","Pleiotropy was found for the associations of obesity, but it is not likely that the observed associations can be primarily explained by pleiotropic effects.","Not discussed","Our ability to perform Mendelianrandomization analysis is limited by the genetic variants identified to date in GWAS, and the variance explained bythese genetic variants for some traits is small. We used 10 instruments in our main analysis, which could lead to false positive findings due to multiple comparisons. However, the associations reported in this study for 2-h glucose, fastinginsulin, BMI and WHRadj BMI were robust, reaching thestringent Bonferroni corrected significance level (P < 0.005).",NA,1605
171,"no","yes","A joint view on genetic variants for adiposity differentiates subtypes with distinct metabolic implications",2018,"Nature Communication","10.1038/s41467-018-04124-9","Winkler","Thomas W Winkler","thomas.winkler@ukr.de","Department of Genetic Epidemiology, University of Regensburg, D-93051 Regensburg, Germany","Effect of class specific adiposity instruments on anthropometric and cardiometabolic traits","it is a current concern whether adjusted-model trait loci like WHRadjBMI loci can reveal meaningful biological information or whether they represent uninterpretable artefacts. We thus investigated the genetic variants that are associated genome-wide with BMI, WHR, or WHRadjBMI in the GIANT data5,6 with regard to their co-association with BMI and WHR and the link of this co-association to metabolic health and pathways. We find that the joint view of the genetic variants across all three of the adiposity traits helps differentiate adiposity subtypes with distinct fat depots and distinct metabolic implications. Furthermore, the joint view helps resolve some of the issues that derive from conducting GWAS on adjusted-model traits.","Two-sample summary-level","type 2 diabetes","type 2 diabetes","metabolic","Type 2 Diabetes","Current study",NA,"both","69033","Not discussed",NA,NA,NA,"healthy","European","BMI","composite measure of BMI and WHR and WHRadjBMI","Current study","18+","both","322154","322154",NA,"Healthy","Europeans",NA,NA,"not discussed","not discussed","p < 5×10-8","Not discussed","Not reported","Not discussed",NA,NA,"25",NA,"We classify 159 signals associated with body mass index (BMI), waist-to-hip ratio (WHR), or WHR adjusted for BMI (WHRadjBMI) at P < 5 × 10−8, into four classes based on the direction of their effects on BMI and WHR.","Not discussed",NA,"Inverse variance weighted",NA,NA,NA,NA,NA,"Not discussed","Not reported","Not discussed","Not discussed","Not discussed","Not discussed","Bonferroni (60 tests)","1kg/m2","not reported","beta","-0.45","0.196",NA,NA,NA,"2.1999999999999999E-2","Not discussed",NA,"not discussed","not discussed","Not discussed","Not discussed",NA,2014
173,"no","yes","The role of glycaemic and lipid risk factors in mediating the effect of BMI on coronary heart disease: a two-step, two-sample Mendelian randomisation study",2017,"Diabetologia","10.1007/s00125-017-4396-y","Xu","Debbie A. Lawlor","d.a.lawlor@bristol.ac.uk","MRC Integrative Epidemiology Unit, University of Bristol, UK.","Effect of body mass index on coronary heart disease and potential mediators","The extent to which effects of BMI on CHD are mediated by glycaemic and lipid risk factors is unclear. In this study we examined the effects of these traits using genetic evidence.","Two-sample summary-level","type 2 diabetes","type 2 diabetes","metabolic","binary outcome","Morris 2012 T2D European both","18+","both","34840","114981","34840","114981",NA,"Case/control","European","BMI","BMI","Locke 2015 BMI European adults both","18+","both","322154","322154",NA,"Healthy","Europeans",NA,NA,"< 0.1","Not discussed","p < 5×10-8","Not discussed","Yes","Not discussed",NA,NA,"77","77",NA,"Not discussed",NA,"Inverse variance weighted","MR Egger","Weighted median",NA,NA,NA,"Consistent with main analysis","F > 500","STATA and R","Not discussed","Not discussed","Not discussed","Not discussed","SD (4.5 kg/m2)","case/control","OR","1.96",NA,"95","1.35","2.83","1E-3","Not discussed","Not discussed","Another potential limitation to our study is that we have assumed no interaction betweenBMI and mediators, but we are not able to test for this because we have used aggregated genome-wide data.","Horizontal pleiotropy is one of the major concerns in relation to limitations of MR studies. However, to explore the potential effects of this pleiotropy, we used different MR methods (IVW, medianbased estimators and MR-Egger) that have different assumptions and we assessed the consistency across each of these estimators. The mediators that we took forward into MR-based mediation analyses (triacylglycerols, HbA1c and type 2 diabetes) had consistent causal effects across these different methods for both steps (i.e. the effect ofBMI on them and of them on CHD). In the mediation analyses, where we include both genetically predicted triacylglycerols and HbA1c, we are assuming that these factors are not causally related to each other. We tested for causal relationships between potential mediators prior to our main two-step MR analyses and these do not suggest any causal effects between triacylglycerols and HbAlc or other glycaemic traits.","Not discussed","Not discussed",NA,2068
181,"no","yes","Causal associations between risk factors and common diseases inferred from GWAS summary data",2018,"NATURE COMMUNICATIONS","10.1038/s41467-017-02317-2","Zhu","Jian Yang","jian.yang@uq.edu.au","Institute for Molecular Bioscience, The University of Queensland, Brisbane, Australia","Method paper: Effect of body mass index and waits hip ratio adjusted for body mass index on 22 traits and a disease count trait","We develop a method (HEIDI-outlier) to detect and eliminate genetic instruments that have apparent pleiotropic effects on both risk factor and disease, and another method (multi-trait-based conditional and joint analysis, or mtCOJO) to estimate the effect of a risk factor on disease conditioning on other risk factors. All methods developed in this study only require summary-level data (with LD between genetic variants from a reference sample with individual-level data), providing a great flexibility to integrate data from multiple studies.","Generalized summary data-based MR (GSMR)","type 2 diabetes","community","metabolic","Type 2 Diabetes (Community)","Current study",NA,"both","13648","160537",NA,NA,NA,"Case/control","European","BMI","BMI","Locke 2015 BMI European adults both","18+","both","322154","322154",NA,"healthy","Europeans","not discussed","HapMap phase II CEU","r2< 0.05","We propose a method (called HEIDI-outlier) to detect pleiotropic SNPs at which the estimates of bxy are significantly different from expected under a causal model, and remove them from the GSMR analysis (Methods).","P< 5.0× 10−8","Not discussed","Not reported","We cleaned the GERA genotype data using the standard quality control (QC) filters (excluding SNPs with missing rate ≥0.02, Hardy–Weinber equilibrium test P-value ≤ 1 × 10−6 or minor allele count < 1, and removing individuals with missing rate ≥0.02), and imputed the genotype data to the 1000G using IMPUTE2.",NA,"80",NA,"77","Probably used all ancestries GWAS not EU as stated, plus use of HEIDI-outlier detection","Yes","We simulated 1,000 independent SNPs from a binomial distribution z ~B(2,f). We then generated x and y under the assumption that x has a causal effect ton y, using the same method as above with 7'"" 2 = 0.6, 7""# 2 = 0.005, n1 =	50,000	and n2 = 20,000. We conducted analyses using GSMR,	MR-Egger1, MR-IVW2,	generalized MR-IVW3, and the Pickrell methods4 based on a random	subset	of the	genome-wide	significant SNPs associated with x, the	number of instruments	m ~U(10,mt) where mt is the total number of genome-wide	significant SNPs. We  ran the simulations with	10,000	replicates.","GSMR","MR Egger","MR-IVW","Generalised MR-IVW",NA,NA,"Consistent with main analysis","Not discussed","R","Not discussed","Not discussed","Not discussed","Not discussed","SD","log odds","OR","3.28750780626394",NA,"95","2.8207098060053","3.83155599815221","< 1.0E-50",NA,NA,"there are several caveats in interpreting the GSMR results. First, if the exposure is a composite trait that comprises multiple sub-phenotypes, we could not rule out the possibility that the effect of exposure on disease is driven by one of the sub-phenotypes. Second, the effect of a risk factor on disease can be non-linear. Fourth, our analyses ignored age-specific and sex-specific effects because of the lack of data from age- and sex-stratified analyses.","results were not driven by pleiotropy and reverse causality. In some cases, the relationship between a risk factor and a disease could be a mixture of multiple models. the intercepts from MR-Egger (a significant deviation of the intercept from 0 is evidence for the presence of pleiotropy) were very small relative to the slopes (Supplementary Fig. 24), and there was no inflation in the test-statistics (Supplementary Fig. 24b, c), suggesting that the degree of pleiotropy was negligible if there was any.","Not discussed","Third, although we have identified a large number of associations, we would expect that associations of small effect size would be missed in our study.",NA,2175
